The mechanism of life-threatening water imbalance in schizophrenia and its relationship to the underlying psychiatric illness

Brain Research Reviews

Volumn 61, Issue 2, 2009, Pages 210-220

  Goldman, Morris B ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Animal model; Hippocampus; HPA axis; Hyponatremia; Oxytocin; Polydipsia; Schizophrenia; Stress; Vasopressin

Indexed keywords

ARGIPRESSIN; BIOLOGICAL MARKER; OXYTOCIN;

ACUTE PSYCHOSIS; ANXIETY DISORDER; BEHAVIOR DISORDER; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE MODEL; DISEASE SEVERITY; DIURESIS; DRUG MECHANISM; FLUID BALANCE; HIPPOCAMPUS; HORMONE BLOOD LEVEL; HUMAN; HYPONATREMIA; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MENTAL DISEASE; MENTAL STRESS; NEUROENDOCRINE SYSTEM; NONHUMAN; PATHOPHYSIOLOGY; POLYDIPSIA; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SOCIAL BEHAVIOR; SOCIAL DISABILITY; SOCIAL STATUS; WATER INTOXICATION;

ANIMALS; ARGININE VASOPRESSIN; BODY WATER; HIPPOCAMPUS; HUMANS; OXYTOCIN; SCHIZOPHRENIA; STRESS, PSYCHOLOGICAL;

EID: 70349615890     PISSN: 01650173     EISSN: 18726321     Source Type: Journal    
DOI: 10.1016/j.brainresrev.2009.06.004     Document Type: Review

References (103)

1. Addington J., Saeedi H., and Addington D. Facial affect recognition: a mediator between cognitive and social functioning in psychosis?. Schizophren. Res. 85 (2006) 142-150
2. Ajlouni K., Kern M.W., Tures J.F., Theil G.B., and Hagen T.C. Thiothixene-induced hyponatremia. Arch. Intern. Med. 134 (1974) 1103-1105
3. Appelgren B.H., Thrasher T.N., Keil L.C., and Ramsay D.J. Mechanism of drinking-induced inhibition of vasopressin secretion in dehydrated dogs. Am. J. Physiol. 261 (1991) R1226-R1233
4. Arango C., Kirkpatrick B., and Koenig J. At issue: stress, hippocampal neuronal turnover, and neuropsychiatric disorders. Schizophr. Bull. 27 (2001) 477-480
5. Arieti S. Interpretation of Schizophrenia. 2nd Edition (1974), Basic Books, New York 415-422
6. Barahal H.S. Water intoxication in a mental case. J. Psych. Quat. 12 (1938) 767-771
7. Baumgartner T., Heinrichs M., Fischbacher U., and Fehr E. Oxytocin shapes the neural circuitry of trust and trust adaptation in humans. Neuron 58 (2008) 639-650
8. Berl T. Psychosis and water balance. N. Engl. J. Med. 318 (1988) 441-442
9. Born J., Lange T., Kern W., McGregor G.P., Bickel U., and Fehm H.L. Sniffing neuropeptides: a transnasal approach to the human brain. Nat. Neurosci. 5 (2002) 514-516
10. Bozikas V.P., Kosmidis M.H., Anezoulaki D., Giannakou M., Andreou C., and Karavatos A. Impaired perception of affective prosody in schizophrenia. J. Neuropsych. Clin. Neurosci. 18 (2006) 81-85
11. Bralet M.C., Ton T., and Falissard B. Schizophrenic patients with polydipsia and water intoxication more often have a form of schizophrenia first described by Kraepelin. Psychiatry Res. 152 (2007) 267-271
12. Bullinger M., Naber D., Pickar D., Cohen R.M., Kalin N.H., Pert A., and Bunney Jr. W.E. Endocrine effects of the cold pressor test: relationships to subjective pain appraisal and coping. Psychiatry Res. 12 (1984) 227-233
13. Caldwell H.K., Lee H.J., Macbeth A.H., and Young W.S. Vasopressin: behavioral roles of an "original" neuropeptide. Prog. Neurobiol. 84 (2008) 1-24
14. Caldwell, H.K., Stephens, S.L., Young W.S., 2008b. Oxytocin as a natural antipsychotic: a study using oxytocin knockout mice, Mol. Psychiatry 2008b (online: PMID: 18227836).
15. Carter C.S. Neuroendocrine perspectives on social attachment and love. Psychoneuroendocrinology 23 (1999) 779-818
16. Chen X.Q., Fawcett J.R., Rahman Y.E., Ala T.A., and Frey W.H. Delivery of nerve growth factor to the brain via the olfactory pathway. J. Alzeheimer's Dis. 1 (1998) 35-44
17. Chrapusta S.J., Egan M.F., Wyatt R.J., Weinberger D.R., and Lipska B.K. Neonatal ventral hippocampal damage modifies serum corticosterone and dopamine release responses to acute footshock in adult Sprague-Dawley rats. Synapse 47 (2003) 270-277
18. Coccaro E.F., Prudic J., Rothpearl A., and Nurnberg H.G. Effect of hospital admission on DST results. Am. J. Psychiatry 141 (1984) 982-985
19. Conrad A.J., and Scheibel A.B. Schizophrenia and the hippocampus: the embryological hypothesis extended. Schizophr. Bull. 13 (1987) 577-587
20. de Leon J., Verghese C., Tracy J.I., Josiassen R.C., and Simpson G.M. Polydipsia and water intoxication in psychiatric patients: a review of the epidemiological literature. Biol. Psychiatry 35 (1994) 408-419
21. de Winter R.F., van Hemert A.M., DeRijk R.H., Zwinderman K.H., Frankhuijzen-Sierevogel A.C., Wiegant V.M., and Goekoop J.G. Anxious-retarded depression: relation with plasma vasopressin and cortisol. Neuropsychopharm. 28 (2003) 140-147
22. Devenport L.D., Devenport J.A., and Holloway F.A. Reward-induced stereotypies: modulation by the hippocampus. Science 212 (1981) 1288-1289
23. Ditzen B., Schaer M., Gabriel B., Bodenmann G., Ehlert U., and Heinrichs M. Intranasal oxytocin increases positive communication and reduces cortisol levels during couple conflict. Biol. Psychiatry 65 (2009) 728-731
24. Domes G., Heinrichs M., Michel A., Berger C., and Herpertz S.C. Oxytocin improves "mind-reading" in humans. Biol. Psychiatry 61 (2007) 731-733
25. Elkashef A.M., Leadbetter R.A., and Kirch D.G. Structural brain imaging in patients with schizophrenia and polydipsia-hyponatremia syndrome. In: Schnur D., and Kirch D.G. (Eds). Water Balance in Schizophrenia (1996), APA Press, Washington, USA 125-136
26. Engelmann M., Landgraf R., and Wotjak C.T. The hypothalamic-neurohypophysial system regulates the hypothalamic-pituitary-adrenal axis under stress: an old concept revisited. Front. Neuroendocrinol. 25 (2004) 132-149
27. Feifel D., and Rez T. Oxytocin modulates psychotomimetic-induced deficits in sensorimotor gating. Psychopharmacology (Berl.) 141 (1999) 93-98
28. Fleischhacker W.W., Barnas C., and Ledochowski M. Hyponatremia-induced organic mental disorder may mask paranoid schizophrenia. Biol. Psychiatry 22 (1987) 650-652
29. Gillum D.M., and Linas S.L. Water intoxication in a psychotic patient with normal renal water excretion. Am. J. Med. 77 (1984) 773-774
30. Goetz R.R., Corcoran C., Yale S., Stanford A.D., Kimhy D., Amador X., and Malaspina D. Validity of a 'proxy' for the deficit syndrome derived from the Positive And Negative Syndrome Scale (PANSS). Schizophr. Res. 93 (2007) 169-177
31. Goldman M.B., and Mitchell C.P. What is the functional significance of the hippocampal pathology in schizophrenia?. Schizophren. Bull. 30 (2004) 367-392
32. Goldman M.B., Luchins D.J., and Robertson G.L. Mechanisms of altered water metabolism in psychotic patients with polydipsia and hyponatremia. N. Engl. J. Med. 318 (1988) 397-403
33. Goldman M.B., Marks R.C., Blake L., Petkovic M., Hedeker D., and Luchins D.J. Estimating daily urine volume in psychiatric patients: empiric conformation. Biol. Psychiatry 31 (1992) 1228-1231
34. Goldman M.B., Blake L., Marks R.C., Hedeker D., and Luchins D.J. Association of nonsuppression of cortisol on the DST with primary polydipsia in chronic schizophrenia. Am. J. Psychiatry 150 (1993) 653-655
35. Goldman M.B., Robertson G.L., and Hedeker D. Oropharyngeal regulation of water balance in polydipsic schizophrenics. Clin. Endocrinol. 44 (1996) 31-37
36. Goldman M.B., Robertson G.L., Luchins D.J., and Hedeker D. The influence of polydipsia on water excretion in hyponatremic, polydipsic schizophrenic patients. J. Clin. Endocrinol. Metab. 81 (1996) 1465-1470
37. Goldman M.B., Robertson G.L., Luchins D.J., Hedeker D., and Pandey G.N. Psychotic exacerbations and enhanced vasopressin secretion in schizophrenics with hyponatremia and polydipsia. Arch. Gen. Psychiatry 54 (1997) 443-449
38. Goldman M.B., Hussain N., and Gnerlich J. Neuroendocrine responses to a cold pressor stimulus in polydipsic hyponatremic and in matched schizophrenic patients. Neuropsychopharm. 32 (2007) 1611-1621
39. Goldman M.B., Torres I.J., Keedy S., Marlow-O'Connor M., Beenken B., and Pilla R. Reduced anterior hippocampal formation volume in hyponatremic schizophrenic patients. Hippocampus 17 (2007) 554-562
40. Goldman M.B., Wood G., Goldman M.B., Gavin M., Paul S., Zaheer S., Fayyaz G., and Pilla R.S. Diminished glucocorticoid negative feedback in polydipsic hyponatremic schizophrenic patients. J. Clin. Endocrinol. Metab. 92 (2007) 698-704
41. Goldman M.B., Marlow-O'Connor M., Torres I., and Carter C.S. Preliminary data on plasma oxytocin in schizophrenic patients with neuroendocrine dysfunction and emotional deficits in press. Schizophrenia Res. 98 (2008) 247-255
42. Gomes A., Lee R., Carter C.S., and Goldman M.B. Effect of Intranasal Oxytocin on Facial Affect Recognition in Schizophrenia (2008), Abstracet SFN, Washington, DC
43. Goursaud A.P., Mendoza S.P., and Capitanio J.P. Do neonatal bilateral ibotenic acid lesions of the hippocampal formation or of the amygdala impair HPA axis responsiveness and regulation in infant rhesus macaques (Macaca mulatta)?. Brain Res. 1071 (2006) 97-104
44. Gray J.A. Integrating schizophrenia. Schizophr. Bull. 24 (1998) 249-266
45. Guastella A.J., Mitchell P., and Dadds M.R. Oxytocin increases gaze to the eye region of human faces. Biol. Psychiatry 63 (2008) 3-5
46. Guastella A.J., Howard A.L., Dadds M.R., Mitchell P., and Carson D.S. A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder. Psychoneuroendocrinology 34 (2009) 917-923
47. Gunduz-Bruce H., Szeszko P.R., Gueorguieva R., Ashtari M., Robinson D.G., Kane J.M., and Bilder R.M. Cortisol levels in relation to hippocampal sub-regions in subjects with first episode schizophrenia. Schizophr. Res. 94 (2007) 281-287
48. Hariprasad M.K., Eisinger R.P., Nadler I.M., Padmanabhan C.S., and Nidus B.D. Hyponatremia in psychogenic polydipsia. Arch. Intern. Med. 140 (1980) 1639-1642
49. Heinrichs M., Baumgartner T., Kirschbaum C., and Ehlert U. Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biol. Psychiatry 54 (2003) 1389-1398
50. Heinrichs M., Dawans B.V., and Domes G. Oxytocin, Vasopressin, and Human Social Behavior. Front. Neuroendocrinol. 30 (2009) 548-557 PMID:19505497
51. Herman J.P., and Mueller N.K. Role of the ventral subiculum in stress integration. Behav. Brain Res. 174 (2006) 215-224
52. Herman J.P., Tasker J.G., Ziegler D.R., and Cullinan W.E. Local circuit regulation of paraventricular nucleus stress integration glutamate-GABA connections. Pharm. Biochem. Behav. 71 (2002) 457-468
53. Hobson J.A., and English J.T. Self-induced water intoxication. Ann. Int. Med. 58 (1963) 324-332
54. Hollander E., Novotny S., Hanratty M., Yaffe R., DeCaria C.M., Aronowitz B.R., and Mosovich S. Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders. Neuropsychopharm. 28 (2003) 193-198
55. Hoskins R.G., and Sleeper F.H. Organic functions in schizophrenia. Arch. Neurol. Psychiatry 30 (1933) 123-140
56. Jahn H., Doring W.K., Krampe H., Sieg S., Werner C., Poser W., Brunner E., and Ehrenreich H. Preserved vasopressin response to osmostimulation despite decreased basal vasopressin levels in long-term abstinent alcoholics. Alcohol Clin. Exp. Res. 28 (2004) 1925-1930
57. Jansen L.M., Gispen-de Wied C.C., and Kahn R.S. Selective impairments in the stress response in schizophrenic patients. Psychopharmacology (Berl) 149 (2000) 319-325
58. Josiassen R.C., Goldman M., Jessani M., Shaughnessy R.A., Albazzaz A., Lee J., Ouyang J., Orlandi C., and Czerwiec F. Double-blind, placebo-controlled, multicenter trial of a vasopressin V2-receptor antagonist in patients with schizophrenia and hyponatremia. Biol. Psychiatry 64 (2008) 1097-1100
59. Keri S., Kiss I., and Keleman O. Sharing secrets: oxytocin and trust in schizophrenia. Soc. Neurosci. 1 (2008) 1-7
60. Kirkpatrick B. Affiliation and neuropsychiatric disorders: the deficit syndrome of schizophrenia. Ann. N.Y. Acad. Sci. 807 (1997) 455-468
61. Kirkpatrick B., Buchanan R.W., Ross D.E., and Carpenter W.T. A separate disease within the syndrome of schizophrenia. Arch. Gen, Psychiatry 58 (2001) 165-171
62. Kishimoto T., Hirai M., Ohsawa H., Terada M., Matsuoka I., and Ikawa G. Manner of arginine vasopressin secretion in schizophrenic patients-with reference to the mechanism of water intoxication. Jpn. J. Psychiatry Neurol. 43 (1989) 161-169
63. Kosfeld M., Heinrichs M., Zak P.J., Fischbacher U., and Fehr E. Oxytocin increases trust in humans. Nature 435 (2005) 673-676
64. Kucharska-Pietura K., David A.S., Masiak M., and Phillips M.L. Perception of facial and vocal affect by people with schizophrenia in early and late stages of illness. Br. J. Psychiatry 187 (2005) 523-528
65. Lee P.R., Brady D.L., Shapiro R.A., Dorsa D.M., and Koenig J.I. Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin. Neuropsychopharm. 30 (2005) 1883-1894
66. Lee P.R., Brady D.L., Shapiro R.A., Dorsa D.M., and Koenig J.I. Prenatal stress generates deficits in rat social behavior: Reversal by oxytocin. Brain Res. 1156 (2007) 152-167
67. Legros J.J. Inhibitory effect of oxytocin on corticotrope function in humans: are vasopressin and oxytocin ying-yang neurohormones?. Psychoneuroendocrinology 26 (2001) 649-655
68. Lipska B.K. Using animal models to test a neurodevelopmental hypothesis of schizophrenia. J. Psychiatry and Neurosci. 29 (2004) 282-286
69. Lodge D.J., and Grace A.A. Aberrant hippocampal activity underlies the dopamine dysregulation in an animal model of schizophrenia. J. Neurosci. 27 (2007) 11424-11430
70. Loup F., Tribollet E., Dubois-Dauphin M., and Dreifuss J.J. Localization of high-affinity binding sites for oxytocin and vasopressin in the human brain. An autoradiographic study. Brain Res. 555 (1991) 220-232
71. Luchins D.J. A possible role of hippocampal dysfunction in schizophrenic symptomatology. Biol. Psychiatry 28 (1990) 87-91
72. Luchins D.J., Goldman M.B., Dyson V., and Lieb M. Excessive stereotypic behaviors in chronic schizophrenia. Schizophren. Res. 8 (1992) 119-123
73. Luchins D.J., Nettles K.W., and Goldman M.B. Anterior medial temporal lobe volumes in polydipsic schizophrenic patients with and without hypo-osmolemia: A pilot study. Biol. Psychiatry 42 (1997) 767-770
74. Ludwig M., and Leng G. Dendritic peptide release and peptide-dependent behaviours. Nature Rev. Neurosci. 7 (2006) 126-136
75. Maier S.F., Amat J., Baratta M.V., Paul E., and Watkins L.R. Behavioral control, the medial prefrontal cortex, and resilience. Dialogues Clin. Neurosci. 8 (2006) 397-406
76. Mednick S., and Schulsinger F. Some premorbid characteristics related to breakdown in children with schizophrenic mothers. In: Rosenthal D., and Kety S. (Eds). The Transmission of Schizophrenia (1968), Pergamon, Oxford, UK 267-293
77. Mitchell C.P., and Goldman M.B. Neonatal lesions of the ventral hippocampal formation disrupt neuroendocrine responses to auditory stress in the adult rat. Psychoneuroendocrinology 29 (2004) 1317-1325
78. Mittleman G., Jones G.H., and Robbins T.W. The relationship between schedule-induced polydipsia and pituitary-adrenal activity: pharmacological and behavioral manipulations. Behav. Brain Res. 28 (1988) 315-324
79. Moses A.M., and Clayton B. Impairment of osmotically stimulated AVP release in patients with primary polydipsia. Am. J. Physiol. 265 (1993) R1247-R1252
80. Nettles K.W., Pesold C., and Goldman M.B. Influence of the ventral hippocampal formation on plasma vasopressin, hypothalamic-pituitary-adrenal axis, and behavioral responses to novel acoustic stress. Brain Res. 858 (2000) 181-190
81. Neumann I., Ludwig M., Engelmann M., Pittman Q.J., and Landgraf R. Simultaneous microdialysis in blood and brain: oxytocin and vasopressin release in response to central and peripheral osmotic stimulation and suckling in the rat. Neuroendocrin. 58 (1993) 637-645
82. Olsson K., and Högberg M. Plasma vasopressin and oxytocin concentrations increase simultaneously during suckling in goats. J. Dairy Res. 76 (2009) 15-19
83. Pietrowsky R., Struben C., Molle M., Fehm H.L., and Born J. Brain potential changes after IN vs. intravenous administration of vasopressin: evidence for a direct nose-brain pathway for peptide effects in humans. Biol. Psychiatry 39 (1996) 332-340
84. Pruessner J.C., Dedovic K., Khalili-Mahani N., Engert V., Pruessner M., Buss C., Renwick R., Dagher A., Meaney M.J., and Lupien S. Deactivation of the limbic system during acute psychosocial stress: evidence from positron emission tomography and functional magnetic resonance imaging studies. Biol. Psychiatry 63 (2008) 234-240
85. Ragavan, V., Verbalis J., Woods, M., 1984. Psychogenic polydipsia and hyponatremia: evidence for a reset osmostat. Presented at the Seventh International Congress of Endocrinology. Quebec, Canada.
86. Raskind M.A., Orenstein H., and Christopher T.G. Acute psychosis, increased water ingestion, and inappropriate antidiuretic hormone secretion. Am. J. Psychiatry 132 (1975) 907-910
87. Riekkinen P., Legros J.J., Sennef C., Jolkkonen J., Smitz S., and Soininen H. Penetration of DGAVP (ORG 5667) across the blood-brain barrier in human subjects. Peptides 8 (1987) 260-265
88. Rider J.M., Mauger T.F., Jameson J.P., and Notman D.D. Water handling in patients receiving haloperidol decanoate. Ann. Pharmacother. 29 (1995) 663-666
89. Risold P.Y., and Swanson L.W. Structural evidence for functional domains in the rat hippocampus. Science 272 (1996) 1484-1486
90. Robertson G.L. The regulation of vasopressin function in health and disease. Recent Prog. Horm. Res. 33 (1976) 333-385
91. Ross H.E., and Young L.J. Oxytocin and the neural mechanisms regulating social cognition and affiliative behavior. Front. Neuroendocrinol. 30 (2009) 534-547
92. Savaskan E., Ehrhardt R., Schulz A., Walter M., and Schächinger H. Post-learning intranasal oxytocin modulates human memory for facial identity. Psychoneuroendocrinology 33 (2008) 368-374
93. Shutty Jr. M.S., McCulley K., and Pigott B. Association between stereotypic behavior and polydipsia in chronic schizophrenic patients. J. Behav. Ther. Exp. Psychiatry. 26 (1995) 339-343
94. Storm E.E., and Tecott L.H. Social circuits: peptidergic regulation of mammalian social behavior. Neuron 47 (2005) 483-486
95. Suzuki M., Takeuchi O., Mori I., Takegoshi K., and Kurachi M. Syndrome of inappropriate secretion of antidiuretic hormone associated with schizophrenia. Biol. Psychiatry 31 (1992) 1057-1061
96. Targowla R. Des troubles fonctionnel du rein dans les maladies mentales. L'excretion del'eau (Kidney malfunction and mental illness: water excretion). Bulletins et mémoires de la Société médicale des hôpitaux de Paris 47 (1923) 1711-1715
97. Thompson R., Gupta S., Miller K., Mills S., and Orr S. The effects of vasopressin on human facial responses related to social communication. Psychoneuroendocrinology 29 (2004) 35-48
98. Vieweg W.V., David J.J., Rowe W.T., Wampler G.J., Burns W.J., and Spradlin W.W. Death from self-induced water intoxication among patients with schizophrenic disorders. J. Nerv. Ment. Dis. 173 (1988) 161-165
99. Walker E., Mittal V., and Tessner K. Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. Ann. Rev. Clin. Psychol. 4 (2008) 189-216
100. Wotjak C.T., Ganster J., Kohl G., Holsboer F., Landgraf R., and Engelmann M. Dissociated central and peripheral release of vasopressin, but not oxytocin, in response to repeated swim stress: new insights into the secretory capacities of peptidergic neurons. Neuroscience 85 (1998) 1209-1222
101. Zahn T.P., and Pickar D. Autonomic activity in relation to symptom ratings and reaction time in unmedicated patients with schizophrenia. Schizophr. Res. 79 (2005) 257-270
102. Zak P.J., Kurzban R., and Matzner W.T. Oxytocin is associated with human trustworthiness. Horm. Behav. 48 (2005) 522-527
103. Zak P.J., Stanton A.A., and Ahmadi S. Oxytocin increases generosity in humans. PLoS ONE 2 (2007) e1128